Table 2.
Patient characteristics and a comparison between patients with malignant and patients with benign ovarian lesions (n = 290)
| Variable | All (n = 290) | Benign (n = 139) | Malignant (n = 151) | Mann-Whitney U test – p value |
|---|---|---|---|---|
| Age, years, median (Q1, Q3) | 53 (41, 63) | 45 (35, 55) | 58 (49, 66) | p < 0.001 |
| Postmenopausal, n(%) | 158 (54.5) | 48 (34.5) | 110 (72.9) | p < 0.001 |
| Ultrasound variables | ||||
| Mulilocular cyst, n(%) | 131 (45.2) | 46 (33.1) | 85 (56.3) | p < 0.001 |
| Solid areas, n(%) | 199 (68.6) | 52 (37.4) | 147 (97.4) | p < 0.001 |
| Bilateral lesions, n(%) | 64 (22.1) | 3 (2.26) | 61 (40.4) | p < 0.001 |
| Ascites, n(%) | 57 (19.7) | 3 (2.2) | 54 (35.8) | p < 0.001 |
| Metastases in abdominal cavity, n(%) | 57 (19.7) | 1 (0.7) | 56 (37.1) | p < 0.001 |
| Largerst diameter of tumor, mm, median (Q1, Q3) | 67.0 (47.0, 122.8) | 60.0 (50.0, 97.5) | 84.0 (42.5, 140.0) | p = 0.15 |
| Color Score | – | – | – | p < 0.001 |
| Color Score 1, n(%) | 178 (61.4) | 117 (84.2) | 61 (40.4) | |
| Color Score 2, n(%) | 84 (29.0) | 22 (15.8) | 62 (41.1) | |
| Color Score 3, n(%) | 25 (8.6) | 0 (0.0) | 25 (16.6) | |
| Color Score 4, n(%) | 3 (1.0) | 0 (0.0) | 3 (2.0) | |
| RI, PI, PSV not detected, n(%) | 212 (73.1) | 121 (87.1) | 91 (60.3) | p < 0.001 |
| detected RI, median (range) | 0.46 (0–0.73) | 0.45 (0–0.73) | 0.47 (0.20–0.70) | p = 0.506 |
| detected PI, median (range) | 0.70 (0–2.45) | 0.73 (0–1.65) | 0.66 (0.28–2.45) | p = 0.280 |
| detected PSV, median (range) | 14.3 (4.69–56.30) | 14.40 (4.69–23.37) | 14.14 (5.00–56.30) | p = 0.565 |
| Laboratory variables | ||||
| CA125, U/ml, median (Q1, Q3) | 75.5 (24.0, 438.0) | 29.0 (15.0, 65.5) | 291.0 (77.5, 897.0) | p < 0.001 |
| PLT, G/l, median (Q1, Q3) | 287.5 (239.0, 365.0) | 262.0 (231.0, 302.5) | 322.0 (252.0, 424.5) | p < 0.001 |
| D-dimer, μg/ml, median (Q1, Q3) | 0.779 (0.337, 3.039) | 0.354 (0.277, 0.534) | 2.837 (1.207, 6.064) | p < 0.001 |
CA125 cancer antigen 125, PLT platelet count, Q quartile